Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show characteristic clinical, histomorphologic, and …

Neuroendocrine neoplasms (NENs) are heterogeneous tumours with a common phenotype
descended from the diffuse endocrine system. NENs are found nearly anywhere in the body …

Purpose The aim of this single-center retrospective study is to assess whether contrast-
enhanced computed tomography (CECT) radiomics analysis is predictive of …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) arise from neuroendocrine
cells found throughout the gastrointestinal tract and islet cells of the pancreas. The incidence …

A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms
began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET …

Diagnostic imaging plays a pivotal role in the diagnosis, staging, treatment selection and
follow-up for neuroendocrine tumors. The available diagnostic strategies are morphologic …

Detection of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and monitoring of
treatment response relies mainly on morphological imaging such as computed tomography …

Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder, is
characterised by the occurrence of pancreatic neuroendocrine tumours (P-NETs) in …

Pancreatic neuroendocrine tumors (PNETs) account for only 3% of pancreatic malignancies,
but have an increasing incidence, currently 0.3 to 0.4 per 100,000. 1–3 They are notably …

This guideline was created for the first time and is intended as a practical aid for the
diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of …